cachexia

News

ESMO: Pfizer drug helps cancer patients gain weight

Pfizer's anti-GDF-15 antibody ponsegromab was able to achieve weight gain in cancer patients with cachexia – a life-threatening metabolic syndrome caused by the underlying disease with no a

Patients

A new hope in cachexia and an outsider’s view on pharma: the...

In the latest instalment of the pharmaphorum podcast, Editor in Chief Jonah Comstock sits down with Russell Potterfield, CEO at Endevica Pharma.

Views & Analysis

NICE’s track record in cancer drugs: the impact of the CDF and the role of interim funding

Changing focus to cachexia may be key to improved cancer out...

Cachexia could be the next blockbuster area in cancer therapeutics because of its link to survival outcomes. Physician and researcher Dr.

ESMO: Pfizer drug helps cancer patients gain weight

A new hope in cachexia and an outsider’s view on pharma: the...

Changing focus to cachexia may be key to improved cancer out...

Gilead claims first FDA nod for a hepatitis D therapy

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks